Author Zetterberg, Henrik

• 2023 | Journal Article | 
  ​ ​Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity​
  Schilling, S.; Pradhan, A.; Heesch, A.; Helbig, A.; Blennow, K.; Koch, C. & Bertgen, L. et al.​ (2023) 
  Acta Neuropathologica Communications, 11(1).​ DOI: https://doi.org/10.1186/s40478-023-01577-y 
  ​Details  DOI 

• 2023 | Journal Article | Overview
  ​ ​Neurodegenerative disease of the brain: a survey of interdisciplinary approaches​
  Davenport, F.; Gallacher, J.; Kourtzi, Z.; Koychev, I.; Matthews, P. M.; Oxtoby, N. P. & Parkes, L. M. et al.​ (2023) 
  Journal of The Royal Society Interface, 20(198) art. 20220406​.​ DOI: https://doi.org/10.1098/rsif.2022.0406 
  ​Details  DOI  PMID  PMC 

• 2022 | Journal Article
  ​ ​Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum​
  Jansen, W. J.; Janssen, O.; Tijms, B. M.; Vos, S. J. B.; Ossenkoppele, R.; Visser, P. J. & Aarsland, D. et al.​ (2022) 
  JAMA Neurology, 79(3) pp. 228​.​ DOI: https://doi.org/10.1001/jamaneurol.2021.5216 
  ​Details  DOI 

• 2021 | Journal Article | 
  ​ ​Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease​
  Zerr, I.; Villar-Piqué, A.; Hermann, P.; Schmitz, M.; Varges, D.; Ferrer, I. & Riggert, J. et al.​ (2021) 
  Alzheimer's Research & Therapy, 13(1) art. 86​.​ DOI: https://doi.org/10.1186/s13195-021-00815-6 
  ​Details  DOI 

• 2020 | Journal Article
  ​ ​Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study​
  Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al.​ (2020) 
  PLoS Medicine, 17(8) pp. e1003289​.​ DOI: https://doi.org/10.1371/journal.pmed.1003289 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia​
  Llorens, F. ; Hermann, P. ; Villar-Piqué, A. ; Diaz-Lucena, D.; Nägga, K.; Hansson, O. & Santana, I. et al.​ (2020) 
  Nature Communications, 11(1).​ DOI: https://doi.org/10.1038/s41467-020-14373-2 
  ​Details  DOI 

• 2020 | Journal Article | 
  ​ ​Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression​
  Mollenhauer, B. ; Dakna, M.; Kruse, N. ; Galasko, D.; Foroud, T.; Zetterberg, H. & Schade, S.  et al.​ (2020) 
  Movement Disorders, 35(11) pp. 1999​-2008​.​ DOI: https://doi.org/10.1002/mds.28206 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development​
  Vallabh, S. M.; Nobuhara, C. K.; Llorens, F. ; Zerr, I. ; Parchi, P.; Capellari, S. & Kuhn, E. et al.​ (2019) 
  Proceedings of the National Academy of Sciences, 116(16) pp. 7793​-7798​.​ DOI: https://doi.org/10.1073/pnas.1901947116 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid​
  Kranaster, L.; Hoyer, C.; Mindt, S.; Neumaier, M.; Müller, N.; Zill, P. & Schwarz, M. J. et al.​ (2019) 
  European Archives of Psychiatry and Clinical Neuroscience, 270(7) pp. 911​-919​.​ DOI: https://doi.org/10.1007/s00406-019-01086-x 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease​
  Nabers, A.; Hafermann, H.; Wiltfang, J. & Gerwert, K.​ (2019) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11(1) pp. 257​-263​.​ DOI: https://doi.org/10.1016/j.dadm.2019.01.008 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Disease signatures: Biomarkers/indicators of neurodegeneration​
  Zetterberg, H. & Bähr, M. ​ (2019) 
  Molecular and Cellular Neuroscience, 97 pp. 1​-2​.​ DOI: https://doi.org/10.1016/j.mcn.2019.05.004 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD​
  Blennow, K.; Diaz-Lucena, D.; Zetterberg, H.; Villar-Pique, A.; Karch, A.; Vidal, E. & Hermann, P. et al.​ (2019) 
  Journal of Neurology, Neurosurgery & Psychiatry, 90(8) pp. 846​-853​.​ DOI: https://doi.org/10.1136/jnnp-2018-320155 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study​
  Mollenhauer, B.; Bowman, F. D.; Drake, D.; Duong, J.; Blennow, K.; El‐Agnaf, O. & Shaw, L. M. et al.​ (2019) 
  Journal of Neurochemistry, 149(1) pp. 126​-138​.​ DOI: https://doi.org/10.1111/jnc.14569 
  ​Details  DOI  PMID  PMC 

• 2018 | Journal Article
  ​ ​Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study​
  Kranaster, L.; Hoyer, C.; Aksay, S.; Bumb, J.; Müller, N.; Zill, P. & Schwarz, M. et al.​ (2018) 
  Neuropsychobiology, 77(1) pp. 13​-22​.​ DOI: https://doi.org/10.1159/000491401 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry​
  Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al.​ (2018) 
  The World Journal of Biological Psychiatry, 19(4) pp. 244​-328​.​ DOI: https://doi.org/10.1080/15622975.2017.1375556 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease​
  Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al.​ (2018) 
  Alzheimer's & Dementia, 14(7) pp. 913​-924​.​ DOI: https://doi.org/10.1016/j.jalz.2018.02.009 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease​
  Murray, C. E; Gami-Patel, P.; Gkanatsiou, E.; Brinkmalm, G.; Portelius, E.; Wirths, O.   & Heywood, W. et al.​ (2018) 
  Acta Neuropathologica Communications, 6(1) art. 62​.​ DOI: https://doi.org/10.1186/s40478-018-0563-8 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation​
  Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P.   & Lleó, A. et al.​ (2018) 
  Alzheimer's Research & Therapy, 10(1).​ DOI: https://doi.org/10.1186/s13195-018-0359-x 
  ​Details  DOI 

• 2018 | Journal Article
  ​ ​Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia​
  Jansen, W. J.; Ossenkoppele, R.; Tijms, B. M.; Fagan, A. M.; Hansson, O.; Klunk, W. E. & van der Flier, W. M. et al.​ (2018) 
  JAMA Psychiatry, 75(1) pp. 84​.​ DOI: https://doi.org/10.1001/jamapsychiatry.2017.3391 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease​
  Kruse, N.; Heslegrave, A.; Gupta, V.; Foiani, M.; Villar-Piqué, A.; Schmitz, M. & Lehmann, S. et al.​ (2018) 
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10 pp. 461​-470​.​ DOI: https://doi.org/10.1016/j.dadm.2018.06.005 
  ​Details  DOI  PMID  PMC 

Researcher

Sort

Items per Page